Abstract

Mental health conditions have been linked closely to an imbalance of microbiota in the gut,leading to disruption of the microbiome (dysbiosis). Several neurotransmitters, such as GABA (gamma-aminobutyric acid), serotonin, and glutamate, are produced in the gut, which are associated with anxiety and depressive symptoms.Mental health and the gut have been linked closely, and many mental illnesses have been associated with gut dysbiosis.Probioticsare marketedto improve gut health, act as mood enhancers, and be effective in reducing stressas unregulatedover-the-counter supplements.Given healthcare disparities and patient-doctor gaps across the globe,this review aims to appraise the literature on probiotics forthe prevention and treatment of mental disorders.PubMed and Google Scholar databases were searched till March 2023 using the MeSH words "prebiotics," "probiotics," "synbiotics," and "psychobiotics." Out of207 studies, 26 studies met the inclusion criteria and were included in the review.Studies suggestprobioticscould be an effective and economical adjunct therapy; however, due to weak study design and low power, the results are inconclusive. Their use is not without risks, and healthcare providers need close supervision until more robust longitudinal studies are conducted to appraise their efficacy and safety profiles.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call